Literature DB >> 17878461

The epidemiology and economics of chronic obstructive pulmonary disease.

David M Mannino1, Sidney Braman.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease responsible for a large human and economic burden around the world. Cigarette smoking is the main risk factor for COPD in the developed world, although other important risk factors include occupational exposures, air pollution, airway hyperresponsiveness, asthma, and genetic predisposition. In most of the world, COPD prevalence and mortality continue to rise in response to increases in smoking, particularly by women and adolescents. COPD is also an important cause of disability, and is linked to comorbid diseases, such as depression and cardiovascular disease, which adds to the large economic burden associated with this disorder. Better public health and medical interventions that target both the risk factors for COPD and look toward earlier intervention may decrease the growing public health impact of COPD.

Entities:  

Mesh:

Year:  2007        PMID: 17878461     DOI: 10.1513/pats.200701-001FM

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  83 in total

1.  Quantative computerized tomography assessment of lung density as a predictor of postoperative pulmonary morbidity in patients with lung cancer.

Authors:  Tevfik Kaplan; Gokce Kaan Atac; Nesimi Gunal; Bulent Kocer; Aslıhan Alhan; Sezai Cubuk; Orhan Yucel; Ebru Ozan Sanhal; Koray Dural; Serdar Han
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

2.  Tai chi exercise for patients with chronic obstructive pulmonary disease: a pilot study.

Authors:  Gloria Y Yeh; David H Roberts; Peter M Wayne; Roger B Davis; Mary T Quilty; Russell S Phillips
Journal:  Respir Care       Date:  2010-11       Impact factor: 2.258

Review 3.  The economic impact of obstructive sleep apnea.

Authors:  Nayef AlGhanim; Vikram R Comondore; John Fleetham; Carlo A Marra; Najib T Ayas
Journal:  Lung       Date:  2007-12-08       Impact factor: 2.584

4.  Chronic obstructive pulmonary disease: a view from the NHLBI.

Authors:  Antonello Punturieri; Thomas L Croxton; Gail G Weinmann; James P Kiley
Journal:  Am J Respir Crit Care Med       Date:  2008-09-01       Impact factor: 21.405

5.  Pulmonary hypertension in a stable community-based COPD population.

Authors:  Vadim Fayngersh; Fotios Drakopanagiotakis; F Dennis McCool; James R Klinger
Journal:  Lung       Date:  2011-08-04       Impact factor: 2.584

6.  Simulation curriculum can improve medical student assessment and management of acute coronary syndrome during a clinical practice exam.

Authors:  Deborah J DeWaay; Matthew D McEvoy; Donna H Kern; Louise A Alexander; Paul J Nietert
Journal:  Am J Med Sci       Date:  2014-06       Impact factor: 2.378

7.  Inhibition of serine proteases by a new class of cyclosulfamide-based carbamylating agents.

Authors:  Qingliang Yang; Yi Li; Dengfeng Dou; Xiangdong Gan; Swathi Mohan; Christopher S Groutas; Laura E Stevenson; Zhong Lai; Kevin R Alliston; Jiaying Zhong; Todd D Williams; William C Groutas
Journal:  Arch Biochem Biophys       Date:  2008-04-22       Impact factor: 4.013

Review 8.  Perinatal stress and early life programming of lung structure and function.

Authors:  Rosalind J Wright
Journal:  Biol Psychol       Date:  2010-01-18       Impact factor: 3.251

9.  Penalizing hospitals for chronic obstructive pulmonary disease readmissions.

Authors:  Laura C Feemster; David H Au
Journal:  Am J Respir Crit Care Med       Date:  2014-03-15       Impact factor: 21.405

10.  New episodes of depression among Medicare beneficiaries with chronic obstructive pulmonary disease.

Authors:  Jennifer S Albrecht; Ting-Ying Huang; Yujin Park; Patricia Langenberg; Ilene Harris; Giora Netzer; Susan W Lehmann; Bilal Khokhar; Linda Simoni-Wastila
Journal:  Int J Geriatr Psychiatry       Date:  2015-08-18       Impact factor: 3.485

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.